STIFEL FINANCIAL CORP - CUE BIOPHARMA INC ownership

CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 65 filers reported holding CUE BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
STIFEL FINANCIAL CORP ownership history of CUE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$338,592
-37.0%
147,212
-0.1%
0.00%
-100.0%
Q2 2023$537,722
+2.8%
147,321
+0.6%
0.00%0.0%
Q1 2023$522,879
+40.7%
146,464
+12.4%
0.00%0.0%
Q4 2022$371,538
+151.0%
130,363
+95.6%
0.00%
Q3 2022$148,000
-10.3%
66,6560.0%0.00%
Q2 2022$165,000
-49.2%
66,6560.0%0.00%
Q1 2022$325,000
-56.9%
66,6560.0%0.00%
-100.0%
Q4 2021$754,000
-21.5%
66,656
+1.2%
0.00%0.0%
Q3 2021$960,000
+25.0%
65,8860.0%0.00%0.0%
Q2 2021$768,000
-4.5%
65,8860.0%0.00%0.0%
Q1 2021$804,000
-2.4%
65,8860.0%0.00%0.0%
Q4 2020$824,000
-16.9%
65,8860.0%0.00%
-50.0%
Q3 2020$991,000
-38.6%
65,8860.0%0.00%
-50.0%
Q2 2020$1,615,000
+103.9%
65,886
+18.0%
0.00%
+100.0%
Q1 2020$792,000
-10.7%
55,8550.0%0.00%0.0%
Q4 2019$887,000
+88.3%
55,8550.0%0.00%
+100.0%
Q3 2019$471,000
-6.2%
55,8550.0%0.00%0.0%
Q2 2019$502,00055,8550.00%
Other shareholders
CUE BIOPHARMA INC shareholders Q3 2022
NameSharesValueWeighting ↓
Prosight Management, LP 829,042$9,376,0005.61%
P.A.W. CAPITAL CORP 120,000$1,357,0001.24%
Nantahala Capital Management 2,539,700$28,724,0001.01%
Slate Path Capital LP 1,483,619$16,780,0000.88%
SANDERS MORRIS HARRIS LLC 359,113$4,416,0000.76%
APOGEM CAPITAL LLC 62,295$705,0000.46%
Robertson Stephens Wealth Management, LLC 478,500$5,411,0000.46%
Bleichroeder LP 200,000$2,262,0000.35%
ADVISORY RESEARCH INC 257,225$2,909,0000.23%
Granite Point Capital Management, L.P. 110,000$1,244,0000.21%
View complete list of CUE BIOPHARMA INC shareholders